[1]
|
American Diabetes Association (2011) Position statement: Standards of medical care in diabetes—2011. Diabetes Care, 34, S11-S61.
|
[2]
|
American Diabetes Association, c1995-2011. Statistics.
http://www.diabetes.org/diabetes-basics/diabetes-statistics/?loc=DropDownDB-stats
|
[3]
|
Lloyd-Jone, D., Adams, R.J., Brown, T.M., Carnethon, M., Dai, S., De Simone, G., et al. (2010) Heart disease and stroke statistics—2010 update: A report from the American Heart Association. Circulation, 121, e46-e215.
doi:10.1161/CIRCULATIONAHA.109.192667
|
[4]
|
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation, 106, 31433421.
|
[5]
|
Laakso, M. (2010) Cardiovascular disease in type 2 diabetes from population to man to mechanisms. Diabetes Care, 33, 442-449. doi:10.2337/dc09-0749
|
[6]
|
Pignone, M., Alberts, M.J., Colwell, J.A., Cushman, M., Inzucchi, S.E., Mukherjee, D., et al. (2010) Aspirin for primary prevention of cardiovascular events in people with diabetes. Circulation, 121, 2694-2701.
doi:10.1161/CIR.0b013e3181e3b133
|
[7]
|
US Preventive Services Task Force (2002) Aspirin for the primary prevention of cardiovascular events: Recommendation and rationale. Annals of Internal Medicine, 136, 157-160.
|
[8]
|
Stafford, R.S., Monti, V. and Ma, J. (2005) Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease. PLoS Medicine, 2, e353.
doi:10.1371/journal.pmed.0020353
|
[9]
|
Rolka, D.B., Fagot-Campagna, A. and Narayan, K.M. (2001) Aspirin use among adults with diabetes. Diabetes Care, 24, 197-201. doi:10.2337/diacare.24.2.197
|
[10]
|
Lee, H.Y., Tong, Y.P., Xing, S. and Cooke, C.E. (2010) Aspirin use in elderly women receiving medication therapy management services. Advances in Therapy, 27, 613622. doi:10.1007/s12325-010-0046-1
|
[11]
|
Brown, D.W., Shepard, D., Giles, W.H., Greenlund, K.J. and Croft, J.B. (2005) Racial differences in the use of aspirin: An important tool for preventing heart disease and stroke. Ethnicity and Disease, 15, 620-626.
|
[12]
|
Berlie, H.D., Hammad, A. and Jaber, L.A. (2007) The use of glucose-lowering agents and aspirin among Arab Americans with diabetes. Ethnicity and Disease, 17, 4245.
|
[13]
|
Lee, R., Onopa, J., Mau, M.K. and Seto, T.B. (2010) Diabetes care in a predominantly Native Hawaiian and Pacific Islander outpatient population. Hawaii Medical Journal, 69, 28-30.
|
[14]
|
Sanchez, D.R., Diez-Roux, A.V., Michos, E.D., Blumenthal, R.S., Schreiner, P.J., Burke, G.L. and Watson, K. (2011) Comparison of the racial/ethnic prevalence of regular aspirin use for the primary prevention of coronary heart disease from the multi-ethnic study of Atherosclerosis. American Journal of Cardiology, 107, 41-46.
doi:10.1016/j.amjcard.2010.08.041
|
[15]
|
Mokdad, A.H., Stroup, D.F. and Giles, W.H. (2003) Public health surveillance for behavioral risk factors in a changing environment: Recommendations from the behavioral risk factor surveillance team. Morbidity and Mortality Weekly Report, 52, RR09.
|
[16]
|
Antithrombotic Trialists’ (ATT) Collaboration (2009) Aspirin in the primary and secondary prevention of vascular disease: Collaborative meta-analysis of individual participant data from randomised trials. Lancet, 373, 18491860. doi:10.1016/S0140-6736(09)60503-1
|
[17]
|
Buse, J.B., Ginsberg, H.N., Bakris, G.L., Clark, N.G., Costa, F., Eckel, R., Fonseca, V., Gerstein, H.C., Grundy, S., Nesto, R.W., Pignone, M.P., Plutzky, J., Porte, D., Redberg, R., Stitzel, K.F. and Stone, N.J. (2007) Primary prevention of cardiovascular diseases in people with diabetes mellitus: A scientific statement from the American Heart Association and the American Diabetes Association. Circulation, 115, 114-126.
doi:10.1161/CIRCULATIONAHA.106.179294
|
[18]
|
Link, B.G. and Phelan, J.C. (1996) Editorial: Understanding sociodemographic differences in health-the role of fundamental social causes. American Journal of Public Health, 86, 471-473. doi:10.2105/AJPH.86.4.471
|
[19]
|
Smith, M., Bates, D.W., Bodenheimer, T. and Cleary, P.D. (2010) Why pharmacists belong in the medical home. Health Affairs, 29, 906-913.
doi:10.1377/hlthaff.2010.0209
|
[20]
|
Goode, K.R. (2006) Change in community pharmacy practice—It is not just coming from the cash register. US Pharmacy Review.
|
[21]
|
Krantz, M.J., Berger, J.S. and Hiatt, W.R. (2010) An aspirin a day: Are we barking up the wrong willow tree? Pharmacotherapy, 30, 115-118.
doi:10.1592/phco.30.2.115
|